Literature DB >> 27440427

Inflammatory myopathies: Choosing the right biomarkers to predict ILD in myositis.

Takahisa Gono1, Masataka Kuwana2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27440427     DOI： 10.1038/nrrheum.2016.120

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  10 in total

1.  Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis.

Authors:  Takahisa Gono; Shinji Sato; Yasushi Kawaguchi; Masataka Kuwana; Masanori Hanaoka; Yasuhiro Katsumata; Kae Takagi; Sayumi Baba; Yuko Okamoto; Yuko Ota; Hisashi Yamanaka
Journal:  Rheumatology (Oxford)       Date:  2012-05-15       Impact factor: 7.580

2.  Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease.

Authors:  Takahisa Gono; Hirotaka Kaneko; Yasushi Kawaguchi; Masanori Hanaoka; Sayuri Kataoka; Masataka Kuwana; Kae Takagi; Hisae Ichida; Yasuhiro Katsumata; Yuko Ota; Hidenaga Kawasumi; Hisashi Yamanaka
Journal:  Rheumatology (Oxford)       Date:  2014-06-26       Impact factor: 7.580

Review 3.  Pulmonary manifestations of polymyositis/dermatomyositis.

Authors:  Robert W Hallowell; Dana P Ascherman; Sonye K Danoff
Journal:  Semin Respir Crit Care Med       Date:  2014-03-25       Impact factor: 3.119

4.  Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study.

Authors:  Yasuhito Hamaguchi; Masataka Kuwana; Kana Hoshino; Minoru Hasegawa; Kenzo Kaji; Takashi Matsushita; Kazuhiro Komura; Motonobu Nakamura; Masanari Kodera; Norihiro Suga; Akira Higashi; Koji Ogusu; Kiyohiro Tsutsui; Akira Furusaki; Hiroshi Tanabe; Shunsuke Sasaoka; Yoshinao Muro; Mika Yoshikawa; Naoko Ishiguro; Masahiro Ayano; Eiji Muroi; Keita Fujikawa; Yukihiro Umeda; Masaaki Kawase; Eriko Mabuchi; Yoshihide Asano; Kinuyo Sodemoto; Mariko Seishima; Hidehiro Yamada; Shinichi Sato; Kazuhiko Takehara; Manabu Fujimoto
Journal:  Arch Dermatol       Date:  2011-04

Review 5.  Utility of anti-melanoma differentiation-associated gene 5 antibody measurement in identifying patients with dermatomyositis and a high risk for developing rapidly progressive interstitial lung disease: a review of the literature and a meta-analysis.

Authors:  Zhiyong Chen; Mengshu Cao; Maria Nieves Plana; Jun Liang; Hourong Cai; Masataka Kuwana; Lingyun Sun
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-08       Impact factor: 4.794

Review 6.  Recent Treatment of Interstitial Lung Disease with Idiopathic Inflammatory Myopathies.

Authors:  Hidenaga Kawasumi; Takahisa Gono; Yasushi Kawaguchi; Hisashi Yamanaka
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2015-07-23

7.  Prognostic factors for myositis-associated interstitial lung disease.

Authors:  Tomoyuki Fujisawa; Hironao Hozumi; Masato Kono; Noriyuki Enomoto; Dai Hashimoto; Yutaro Nakamura; Naoki Inui; Koshi Yokomura; Naoki Koshimizu; Mikio Toyoshima; Toshihiro Shirai; Kazumasa Yasuda; Hiroshi Hayakawa; Takafumi Suda
Journal:  PLoS One       Date:  2014-06-06       Impact factor: 3.240

Review 8.  Factors Associated with Interstitial Lung Disease in Patients with Polymyositis and Dermatomyositis: A Systematic Review and Meta-Analysis.

Authors:  Li Zhang; Guoqin Wu; Di Gao; Guijian Liu; Lin Pan; Liyan Ni; Zheng Li; Qiang Wang
Journal:  PLoS One       Date:  2016-05-12       Impact factor: 3.240

9.  Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome.

Authors:  Yasuhito Hamaguchi; Manabu Fujimoto; Takashi Matsushita; Kenzo Kaji; Kazuhiro Komura; Minoru Hasegawa; Masanari Kodera; Eiji Muroi; Keita Fujikawa; Mariko Seishima; Hidehiro Yamada; Ryo Yamada; Shinichi Sato; Kazuhiko Takehara; Masataka Kuwana
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

10.  Clinical Utility of an Enzyme-Linked Immunosorbent Assay for Detecting Anti-Melanoma Differentiation-Associated Gene 5 Autoantibodies.

Authors:  Shinji Sato; Akihiro Murakami; Akiko Kuwajima; Kazuhiko Takehara; Tsuneyo Mimori; Atsushi Kawakami; Michiaki Mishima; Takafumi Suda; Mariko Seishima; Manabu Fujimoto; Masataka Kuwana
Journal:  PLoS One       Date:  2016-04-26       Impact factor: 3.240
  10 in total
  6 in total

1.  Interstitial Lung Disease in Dermatomyositis Without Myositis-Specific and Myositis-Associated Autoantibodies: Study of a Series of 72 Patients From a Single Cohort.

Authors:  Fang Chen; Jinping Wang; Puli Zhang; Yu Zuo; Lifang Ye; Guochun Wang; Xiaoming Shu
Journal:  Front Immunol       Date:  2022-05-06       Impact factor: 8.786

2.  Mortality Risk Stratification Using Cluster Analysis in Patients With Myositis-Associated Interstitial Lung Disease Receiving Initial Triple-Combination Therapy.

Authors:  Takahisa Gono; Kenichi Masui; Shinji Sato; Masataka Kuwana
Journal:  Front Med (Lausanne)       Date:  2022-05-09

3.  Evaluation of usefulness in surfactant protein D as a predictor of mortality in myositis-associated interstitial lung disease.

Authors:  Shinjiro Kaieda; Takahisa Gono; Kenichi Masui; Naoshi Nishina; Shinji Sato; Masataka Kuwana
Journal:  PLoS One       Date:  2020-06-11       Impact factor: 3.240

4.  A 62-Year-Old Woman With Lung Cancer, Ulcerating Rash, and Rapidly Progressive Hypoxemia.

Authors:  Yukiko Kunitomo; Grant Young; Rupak Datta; Lisa L Korn; Lynn Tanoue; Samir Gautam
Journal:  Chest       Date:  2020-10       Impact factor: 9.410

5.  Initial predictors for short-term prognosis in anti-melanoma differentiation-associated protein-5 positive patients.

Authors:  Qihua Yang; Tianfang Li; Xin Zhang; Kunlong Lyu; Shujun Wu; Yan Chen; Shengyun Liu; Zujiang Yu
Journal:  Orphanet J Rare Dis       Date:  2021-01-30       Impact factor: 4.123

6.  Dermatomyositis Which Was Double Positive for Anti-MDA5 and Anti-ARS Antibodies That Was Successfully Treated by Intensive Immunosuppressive Therapy.

Authors:  Satoshi Hama; Misako Higashida-Konishi; Mitsuhiro Akiyama; Tatsuya Shimada; Hiroshi Takei; Keisuke Izumi; Hisaji Oshima; Yutaka Okano
Journal:  Intern Med       Date:  2022-04-01       Impact factor: 1.271
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.